Update on global epidemiology of viral hepatitis and preventive strategies
- PMID: 30430114
- PMCID: PMC6232563
- DOI: 10.12998/wjcc.v6.i13.589
Update on global epidemiology of viral hepatitis and preventive strategies
Abstract
Viral hepatitis is one of the major public health concerns around the world but until recently it has drawn little attention or funding from global health policymakers. Every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. However, the majority of the infected population are unaware of their condition. This population have significant obstacles to overcome such as lack of awareness, vulnerability, increased migration, disease stigma, discrimination, as well as poor health resources, conflict in policy development and program implementation. Despite implementing infection control measures over the last few decades eradication or significant disease reduction remains elusive. This study aims to present the current global prevalence status and examines potential elimination strategies. The information for this research were obtained through a systematic review, published scientific literatures, the official websites of various government organisations, international public health organisations and internationally recognised regulatory bodies over a period of 40 years between 1978 and 2018.
Keywords: Cirrhosis; Global epidemiology; Liver cancer; Outreach clinic; Vaccination; Viral hepatitis.
Conflict of interest statement
Conflict-of-interest statement: Nothing to declare.
Figures
Similar articles
-
Sepsis Care Pathway 2019.Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019. Qatar Med J. 2019. PMID: 31763206 Free PMC article.
-
China's efforts to shed its title of "Leader in liver disease".Drug Discov Ther. 2007 Oct;1(2):84-5. Drug Discov Ther. 2007. PMID: 22504391
-
An Update on Viral Hepatitis B and C in Mexico: Advances and Pitfalls in Eradication Strategies.Microorganisms. 2024 Jul 3;12(7):1368. doi: 10.3390/microorganisms12071368. Microorganisms. 2024. PMID: 39065136 Free PMC article. Review.
-
National viral hepatitis control program in India: Call for update.J Family Med Prim Care. 2023 Sep;12(9):1755-1758. doi: 10.4103/jfmpc.jfmpc_1455_23. Epub 2023 Sep 30. J Family Med Prim Care. 2023. PMID: 38024898 Free PMC article.
-
Immigration and viral hepatitis.J Hepatol. 2015 Aug;63(2):515-22. doi: 10.1016/j.jhep.2015.04.026. Epub 2015 May 8. J Hepatol. 2015. PMID: 25962882 Review.
Cited by
-
Protein-driven membrane remodeling: Molecular perspectives from Flaviviridae infections.Biophys J. 2023 Jun 6;122(11):1890-1899. doi: 10.1016/j.bpj.2022.11.015. Epub 2022 Nov 11. Biophys J. 2023. PMID: 36369756 Free PMC article. Review.
-
It Is Time for a Simplified Approach to Hepatitis B Elimination.Gastro Hep Adv. 2022 Oct 14;2(2):209-218. doi: 10.1016/j.gastha.2022.10.004. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39132618 Free PMC article.
-
Associations between polymorphisms in IL-10 gene and the risk of viral hepatitis: a meta-analysis.Gut Pathog. 2020 Jul 28;12:36. doi: 10.1186/s13099-020-00372-7. eCollection 2020. Gut Pathog. 2020. PMID: 32742307 Free PMC article.
-
Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.Front Cell Infect Microbiol. 2022 Apr 4;12:774335. doi: 10.3389/fcimb.2022.774335. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35444959 Free PMC article. Review.
-
Prevalence of Hepatitis B and C Infections and Associated Risk Factors in Pars Cohort Study, Southern Iran.Middle East J Dig Dis. 2021 Apr;13(2):95-102. doi: 10.34172/mejdd.2021.211. Epub 2021 May 29. Middle East J Dig Dis. 2021. PMID: 34712446 Free PMC article.
References
-
- World Health Organization. Prevention and Control of Viral Hepatitis Infection: Frame Work for Global Action. 2012. Available from: http://www.who.int/hepatitis/publications/Framework/en/
-
- Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553–562. - PubMed
-
- Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–2219. - PubMed
-
- Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012;379:2477–2488. - PubMed
-
- Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–6657. - PubMed
Publication types
LinkOut - more resources
Full Text Sources